-
Product Insights
Likelihood of Approval Analysis for Choroidal Neovascularization
Overview How likely is it that the drugs in Choroidal Neovascularization will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Choroidal Neovascularization Overview Choroidal neovascularization (CNV) involves the growth of new blood...
-
Product Insights
Likelihood of Approval Analysis for Leiomyosarcoma
Overview How likely is it that the drugs in Leiomyosarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Leiomyosarcoma Overview Leiomyosarcoma is an aggressive soft tissue sarcoma derived from smooth muscle...
-
Product Insights
Likelihood of Approval Analysis for Salivary Gland Cancer
Overview How likely is it that the drugs in Salivary Gland Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Salivary Gland Cancer Overview Salivary gland cancer refers to malignant tumors...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Biliary Tract Cancer
Overview How likely is it that the drugs in Metastatic Biliary Tract Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Biliary Tract Cancer Overview Metastatic biliary tract cancer, originating...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Hepatocellular Carcinoma (HCC)
Overview How likely is it that the drugs in Metastatic Hepatocellular Carcinoma (HCC) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Hepatocellular Carcinoma (HCC) Overview Metastatic hepatocellular carcinoma (HCC) refers...
-
Product Insights
Likelihood of Approval Analysis for Non-Rhabdomyosarcoma
Overview How likely is it that the drugs in Non-Rhabdomyosarcoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Non-Rhabdomyosarcoma Overview Non-rhabdomyosarcoma refers to a group of cancers that are distinct from...
-
Product Insights
Likelihood of Approval Analysis for Nonmelanomatous Skin Cancer
Overview How likely is it that the drugs in Nonmelanomatous Skin Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nonmelanomatous Skin Cancer Overview Nonmelanoma skin cancer comprises basal cell carcinoma...
-
Product Insights
Likelihood of Approval Analysis for Peripheral T-Cell Lymphomas (PTCL)
Overview How likely is it that the drugs in Peripheral T-Cell Lymphomas (PTCL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral T-Cell Lymphomas (PTCL) Overview Peripheral T-cell lymphomas (PTCL) constitute...
-
Product Insights
Likelihood of Approval Analysis for Squamous Non-Small Cell Lung Cancer
Overview How likely is it that the drugs in Squamous Non-Small Cell Lung Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Squamous Non-Small Cell Lung Cancer Overview Squamous cell carcinoma...
-
Product Insights
Likelihood of Approval Analysis for Swine Influenza
Overview How likely is it that the drugs in Swine Influenza will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Swine Influenza Overview Swine influenza is an infection caused by any of...